Cytomegalovirus in pregnancy: To screen or not to screen

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Walker, Susan P ^a,b,c   Palma Dias, Ricardo ^b,c   Wood, Erica M ^d,f   Shekleton, Paul ^c   Giles, Michelle L ^d,e,f  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Department of Fetal Medicine Unit ^*  (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e SOUTHERN HEALTH   (Australia)

^f MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; VALACICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FETUS ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HYGIENE; MORTALITY; PATIENT COUNSELING; PHYSICIAN; POLYMERASE CHAIN REACTION; PREGNANCY TERMINATION; PREGNANT WOMAN; RISK REDUCTION; SCREENING TEST; SECONDARY PREVENTION; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; URINALYSIS; VERTICAL TRANSMISSION; VIRUS DETECTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; SECONDARY PREVENTION; TERTIARY PREVENTION;

EID: 84876190265     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-96     Document Type: Article

References (44)

1. Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009 Dec, 46(Suppl 4):S6-10.
2. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17(4):253-76. 10.1002/rmv.535, 17579921.
3. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012 Feb 11, 379(9815):547-56.
4. Loane M, Morris JK, Addor MC, Arriola L, Budd J, Doray B, Garne E, Gatt M, Haeusler M, Khoshnood B, Klungsøyr Melve K, Latos-Bielenska A, McDonnell B, Mullaney C, O'Mahony M, Queisser-Wahrendorf A, Rankin J, Rissmann A, Rounding C, Salvador J, Tucker D, Wellesley D, Yevtushok L, Dolk H. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 2013 Jan, 21(1):27-33.
5. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17(5):355-363. 10.1002/rmv.544, 17542052.
6. Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, Rawlinson WD. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 2011 Jun 1, 203(11):1526-1533.
7. Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009, 360(12):1191-9. 10.1056/NEJMoa0804749, 2753425, 19297572.
8. Cahill AG, Odibo AO, Stamilo DM, Macones GA. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 2009, 201(466):e1-7.
9. Wilson JMG, Jungner G. Principles and practice of screening for diseases. Public Health Paper Number 34 1968, 9. Geneva: World Health Organization.
10. Lugnér AK, Mollema L, Ruijs WL, Hahné SJ. A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect 2010 Aug, 138(8):1172-84.
11. Arevalo JA, Washington AE. Cost-effectiveness of Prenatal Screening and Immunization for Hepatitis B Virus. JAMA 1988, 259(3):365-369. 10.1001/jama.1988.03720030025027, 2961895.
12. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Publ Health 2011, 11(3):S9. 2011 Apr 13.
13. Bodéus M, Zech F, Hubinont C, Bernard P, Goubau P. Human cytomegalovirus in utero transmission: Follow-up of 524 maternal seroconversions. J Clin Virol 2010, 47:201-202. 10.1016/j.jcv.2009.11.009, 20006542.
14. Enders G, Daiminger A, Bäder U. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011 Nov, 52(3):244-246.
15. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. New Advances in the diagnosis of congenital CMV infection. J Clin Virol 2008, 41:192-197. 10.1016/j.jcv.2007.10.015, 18054840.
16. Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, Shiboski S, Muci S, Anceschi MM, Aziz N, Adler SP, Pereira L. Antibody Treatment Promotes Compensation for Human Cytomegalovirus-Induced Pathogenesis and a Hypoxia-Like Condition in Placentas with Congenital Infection. Am J Pathol 2010 September, 177(3):1298-1310.
17. Vauloup-Fellous C, Picone O, Cordier AG. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009, 46(4):S49-53.
18. Nigro G, Adler SP, La Torre R, Best AM. Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005 Sep 29, 353(13):1350-1362.
19. Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011 Jan 15, 52(2):e11-3.
20. Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010 Sep, 20(5):311.
21. Nigro G, Anceschi MM, Cosmi EV. The Congenital Cytomegalic Disease Collaborating Group. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003, 110:572-577. 10.1046/j.1471-0528.2003.01302.x, 12798474.
22. Centres for Disease Control and Prevention. Preventing Congenital CMV Infection 2012, http://www.cdc.gov/cmv/prevention.html. Accessed 18.8.2012.
23. Picone O, Vauloup-Fellous C, Cordier AG, Parent Du Châtelet I, Senat MV, Frydman R, Grangeot-Keros L. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 2009 May, 116(6):818-23.11.
24. Guerra B, Simonazzi G, Banfi A, Lazzarotto T, Farina A, Lanari M, Rizzo N. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol 2007, 196:221.e1-221.e6.
25. Liesnard C, Donner C, Brancart F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000 Jun, 95(6 Pt 1):881-888.
26. Enders G, Bäder U, Lindemann L. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001 May, 21(5):362-377.
27. Gabbay-Ben Ziv R, Yogev Y, Peled Y. Congenital cytomegalovirus infection following antenatal negative diagnostic amniotic fluid analysis - A single center experience. J Matern Fetal Neonatal Med. 2012, 25(9):1787-1790. 10.3109/14767058.2012.663832, 22489602.
28. Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997 Jan, 176(1 Pt 1):241-53.
29. Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 2012 Mar 27, 40(4):439-46.
30. Revello MG. Efficacy study of human cytomegalovirus (HCMV) hyperimmune globulin to prevent congenital HCMV infection (CHIP) ClinicalTrials.gov identifier: NCT00881517.
31. Friese K, Mylonas I, Spiess A, Wartenberg-Demand A, Mielke O. Prevention of CMV infection in newborns and fetuses. Epidemiological results of a randomized-trial in primary CMV infection of pregnant women 2010, 23-25. Paris: Abstract Book from the 3rd Congenital Cytomegalovirus Conference, Paris Descartes University.
32. Revello MG. Role Of Antibodies & CMI In Preventing Congenital CMV. The Development and Evaluation of Human Cytomegalovirus Vaccines Public Workshop 01-10-2012 2012, 118-133.
33. Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B, Graf N, Arbuckle S, Craig ME, Rawlinson WD. Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy Outcomes. PLoS One 2012, 7(12):e52899. 10.1371/journal.pone.0052899, 3534118, 23300810.
34. Pass RF, Fowler KB, Sb B. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006 Feb, 35(2):216-220.
35. Simchen MJ, Toi A, Bona M, Alkazaleh F, Ryan G, Chitayat D. Fetal hepatic calcifications: prenatal diagnosis and outcome. Am J Obstet Gynecol 2002, 187(6):2235-2235.
36. Guerra B, Simonazzi G, Puccetti C. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008, 198(380):e1-7.
37. Farkas N, Hoffmann C, Ben-Sira L. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection?. Prenat Diagn 2011 Apr, 31(4):360-366.
38. Benoist G, Salomon LJ, Mohlo M. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 2008 Dec, 32(7):900-905.
39. Lipitz S, Hoffmann C, Feldman B. Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol 2010 Dec, 36(6):709-717.
40. Lipitz S, Yinon Y, Malinger G, Yagel S, Levit L, Hoffman C, Rantzer R, Weisz B. The risk of CMV associated sequelae is higher following first-trimester infection; however, in the presence of normal prenatal imaging the outcome is favorable. Ultrasound Obstet Gynecol 2013, Epub ahead of print.
41. Visentin S, Manara R, Milanese L. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012 Aug, 55(4):497-503.
42. Nigro G, Adler SP, Parruti G. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy-a case-control study of the outcome in children. J Infect Dis 2012 Jan 15, 205(2):215-27.
43. Polilli E, Parruti G, D'Arcangelo F, Tracanna E, Clerico L, Savini V, D'Antonio F, Rosati M, Manzoli L, D'Antonio D, Nigro G. Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection. Clin Vaccine Immunol 2012 Dec, 19(12):1991-3.
44. Jacquemard F, Yamamoto M, Costa JM. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007 Sep, 114(9):1113-1121.